Incontinentia pigmenti (IP) is a rare multisystemic X-linked dominant genetic disorder characterized by specific skin lesions. The disease can be misdiagnosed in infants and may have severe complications affecting the eyes and/or the brain. European Network for Rare Skin Diseases (ERN-Skin) issued multidisciplinary consensus recommendations for the diagnosis and practical management of patients with incontinentia pigmenti in March 2020, which put forward the guidance of the diagnosis, treatment, follow-up, etc. for incontinentia pigmenti. This paper interpreted the consensus to provide references for the diagnosis and management of incontinentia pigmenti.
In May 2021, the British Association of Dermatologists (BAD) published the latest guideline for the management of individuals with rosacea and put forward recommendations on the etiology, natural history, treatment, prognosis, and follow-up of rosacea. This paper aimed to provide references for the diagnosis and treatment of rosacea in China by interpreting the main content of the guideline and comparing it with related guidelines domestically and abroad.